Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284319 · ClinicalTrials.gov registry record · NA
Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04284319 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 10 participants.
The verdict
NCT04284319, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Normothermic regional perfusion (NRP) utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemodynamic and echocardiographic assessment of the donor heart prior to final acceptance for transplantation without the imminent danger of ongoing warm ischemia.
Interventions
- PROCEDURE DCD Heart Transplantation Using NRP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-01-20 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04284319
The ClinicalTrials.gov registry entry for NCT04284319 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DCD Heart Transplantation Using NRP is the first listed.
NCT04284319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04284319 about?
NCT04284319 is a clinical study titled "Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death". Normothermic regional perfusion (NRP) utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemody...
What is the current status of trial NCT04284319?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-01-20. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04284319?
The interventions under investigation include: DCD Heart Transplantation Using NRP (PROCEDURE).
Who is sponsoring clinical trial NCT04284319?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.